Vertex Pharmaceuticals (VRTX) Stock Highlights

451.23 | +0.72%

2024-11-20 23:14:30

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Statistics

Range Today

445.38 451.76

Volume Today 1.64M

Range 1 Year

346.29 519.88

Volume 1 Year 306.43M

Range 3 Year

179.96 519.88

Volume 3 Year 1.03B

Range 10 Year

71.46 519.88

Volume 10 Year 4.05B

Highlights

Market Capitalization 119.93B (large)

Floating Shares 256.75M

Current Price 451.23

Price To Earnings -253.4

Price To Revenue 11.28

Price To Book 7.68

Earnings Per Share -1.89

Payout Ratio 0%

Performance

Latest +0.72%

1 Month -6.03%

3 Months -7.67%

6 Months +1.46%

1 Year +29.01%

3 Years +147.05%

5 Years +110.09%

10 Years +299.74%

Benchmarks

Market Capitalization

1 / 368

Gross Profits

4 / 278

Total Revenue

2 / 300

Total Rank

58 / 368

Free Cashflow

1 / 352

Performance 5 years

65 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.